ACES Diagnostics raises $7.1M in October 2026 SEC filing

By Find your role first team · October 28, 2026, 23:20 UTC

ACES Diagnostics, incorporated in 2024 and based in AZ, has filed three Form D notices with the SEC. These filings indicate an estimated $11.1M raised in seed funding. Round types are estimates, not official designations.

The company's first filing in June 2026 reported a $3.6M raise with a first sale date of June 12, 2024. A second filing on the same day in June 2026 reported a $400K raise, with a first sale date of May 5, 2026. The most recent filing, on October 27, 2026, reported a $7.1M raise with a first sale date of October 22, 2026.

The amounts raised grew from $400K to $3.6M and then to $7.1M in the latest round. Named in the October 2026 filing are Tammy Crawford (Executive Officer, Director), Kim Sablich (Director), Linda Giampa (Director), Todd Snowden (Director), and John McDonough (Director). Find your role does not track open roles for ACES Diagnostics yet.

Every Form D filing

Named in the latest filing

• Tammy CrawfordExecutive Officer, Director
• Kim SablichDirector
• Linda GiampaDirector
• Todd SnowdenDirector
• John McDonoughDirector

From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR